Logo image of NXTC

NEXTCURE INC (NXTC) Stock Overview

USA - NASDAQ:NXTC - US65343E2072 - Common Stock

5.7456 USD
+0.22 (+3.9%)
Last: 9/24/2025, 8:26:11 PM

NXTC Key Statistics, Chart & Performance

Key Statistics
52 Week High19.2
52 Week Low2.69
Market Cap15.40M
Shares2.68M
Float2.28M
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)-25.81
PEN/A
Fwd PEN/A
Earnings (Next)11-05 2025-11-05/amc
IPO05-09 2019-05-09
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology


NXTC short term performance overview.The bars show the price performance of NXTC in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 5 10

NXTC long term performance overview.The bars show the price performance of NXTC in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of NXTC is 5.7456 USD. In the past month the price increased by 10.07%. In the past year, price decreased by -65.3%.

NEXTCURE INC / NXTC Daily stock chart

NXTC Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 20.77 388.63B
AMGN AMGEN INC 12.8 150.32B
GILD GILEAD SCIENCES INC 14.69 141.04B
VRTX VERTEX PHARMACEUTICALS INC 22.23 96.56B
REGN REGENERON PHARMACEUTICALS 12.64 61.15B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 60.08B
ARGX ARGENX SE - ADR 78.72 44.66B
ONC BEONE MEDICINES LTD-ADR 5.77 39.21B
INSM INSMED INC N/A 29.80B
BNTX BIONTECH SE-ADR N/A 23.98B
NTRA NATERA INC N/A 22.50B
BIIB BIOGEN INC 8.6 20.18B

About NXTC

Company Profile

NXTC logo image NextCure, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing immunomedicines to treat cancer and other immune-related diseases. The company is headquartered in Beltsville, Maryland and currently employs 43 full-time employees. The company went IPO on 2019-05-09. The company focuses on advancing therapies that leverage its core strengths in understanding biological pathways and biomarkers, the interactions of cells, including in the tumor microenvironment, and the role each interaction plays in a biologic response. Its product candidate, LNCB74, is designed as a B7-H4 targeted ADC to kill tumors. Its clinical oncology programs include NC410 and NC525. NC410 is a fusion protein of LAIR-2, a naturally occurring soluble version of, and decoy protein for, LAIR-1 that is designed to block immune suppression mediated by LAIR-1. NC525 is a novel LAIR-1 antibody that selectively targets Acute Myeloid Leukemia (AML), blast cells and leukemic stem cells.

Company Info

NEXTCURE INC

9000 Virginia Manor Rd Ste 200

Beltsville MARYLAND 20705 US

CEO: Michael Richman

Employees: 43

NXTC Company Website

NXTC Investor Relations

Phone: 12403994900

NEXTCURE INC / NXTC FAQ

What is the stock price of NEXTCURE INC today?

The current stock price of NXTC is 5.7456 USD. The price increased by 3.9% in the last trading session.


What is the ticker symbol for NEXTCURE INC stock?

The exchange symbol of NEXTCURE INC is NXTC and it is listed on the Nasdaq exchange.


On which exchange is NXTC stock listed?

NXTC stock is listed on the Nasdaq exchange.


What is the price forecast or stock price prediction for NEXTCURE INC stock?

9 analysts have analysed NXTC and the average price target is 17.85 USD. This implies a price increase of 210.67% is expected in the next year compared to the current price of 5.7456. Check the NEXTCURE INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.


What is NEXTCURE INC worth?

NEXTCURE INC (NXTC) has a market capitalization of 15.40M USD. This makes NXTC a Nano Cap stock.


How many employees does NEXTCURE INC have?

NEXTCURE INC (NXTC) currently has 43 employees.


What are the support and resistance levels for NEXTCURE INC (NXTC) stock?

NEXTCURE INC (NXTC) has a support level at 5.57 and a resistance level at 5.76. Check the full technical report for a detailed analysis of NXTC support and resistance levels.


Should I buy NEXTCURE INC (NXTC) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does NEXTCURE INC (NXTC) stock pay dividends?

NXTC does not pay a dividend.


When does NEXTCURE INC (NXTC) report earnings?

NEXTCURE INC (NXTC) will report earnings on 2025-11-05, after the market close.


What is the Price/Earnings (PE) ratio of NEXTCURE INC (NXTC)?

NEXTCURE INC (NXTC) does not have a PE ratio as the earnings reported over the last twelve months were negative (-25.81).


What is the Short Interest ratio of NEXTCURE INC (NXTC) stock?

The outstanding short interest for NEXTCURE INC (NXTC) is 1.74% of its float. Check the ownership tab for more information on the NXTC short interest.


NXTC Technical Analysis

ChartMill assigns a technical rating of 4 / 10 to NXTC. When comparing the yearly performance of all stocks, NXTC is a bad performer in the overall market: 93.24% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

NXTC Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to NXTC. The financial health of NXTC is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

NXTC Financial Highlights

Over the last trailing twelve months NXTC reported a non-GAAP Earnings per Share(EPS) of -25.81. The EPS decreased by -213.23% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -127.76%
ROE -192.53%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-71.06%
Sales Q2Q%N/A
EPS 1Y (TTM)-213.23%
Revenue 1Y (TTM)N/A

NXTC Forecast & Estimates

9 analysts have analysed NXTC and the average price target is 17.85 USD. This implies a price increase of 210.67% is expected in the next year compared to the current price of 5.7456.


Analysts
Analysts80
Price Target17.85 (210.67%)
EPS Next Y-6.73%
Revenue Next YearN/A

NXTC Ownership

Ownership
Inst Owners37.69%
Ins Owners1.65%
Short Float %1.74%
Short Ratio0.25